Pfizer's (NYSE:PFE) stock up by 7.7% over the past three months. However, we decided to study the company's mixed-bag of ...

Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) ...

An expert panel of the EU drug regulator, the European Medicines Agency (EMA) on Friday recommended marketing authorizations ...

Pfizer (PFE) stock in focus as company faces lawsuits over its alleged failure to warn about brain tumor risks linked to Depo ...

Key Points Pfizer stands as one of the largest pharmaceutical companies in the world.Although it has an attractive 7.1% yield, it has a big blemish in its dividend past.Investors looking at drug ...

Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.

Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages - including the XFG and NB.1.8.1 variants1 - compared to ...

These five blue-chip dividend stocks have had a tough 2025 but are solid long-term buys for growth and income investors.

GSK (GSK) stock in focus as the company secures EU approval for Blenrep combo therapies targeting the blood cancer multiple ...

Lee, at this point in the year, all the companies that pay dividends have pretty much set their dividends. You know, the ...

It might be prudent to make a point of collecting a little more cash in the near future, and worry a little less about growth ...

Here are five high-yield dividend stocks that offer passive income and solid entry points that investors can buy and forget ...